New combo therapy targets Tough-to-Treat liver metastases in colon cancer
NCT ID NCT07357220
Summary
This study is testing whether a new two-drug combination (AK112 and VG2025) is safe and effective for people with advanced colorectal cancer that has spread to the liver and has stopped responding to standard treatments. It will enroll about 72 adults to first find the safest dose and then see if the treatment can shrink tumors and control the cancer. The main goals are to check for side effects and measure how many patients' tumors respond to the treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER WITH HEPATIC METASTASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The First Affiliated Hospital, Zhejiang University School of Medicine，No. 79, Qingchun Road, Shangcheng District, Hangzhou City, Zhejiang Province
Hangzhou, Zhejiang, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.